Bromm K, Herrmann W M, Schulz H
Department of Psychiatry, Free University of Berlin, Germany.
Neuropsychobiology. 1995;31(3):156-65. doi: 10.1159/000119186.
Additive analgesic effects of long-term application of a combination of the vitamins B1, B6, B12 (thiamine diphosphate 100 mg, pyridoxsine-HCl 200 mg, cyanocobalamin 20 micrograms, p.o.) on a single dose of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac (diclofenac-Na, 50 mg, p.o.) were investigated with a noninflammatory experimental pain model in 38 healthy volunteers. B-vitamins were given with 3 dosages/day for 1 week. Then experimental sessions of 3 h followed to test the analgesic efficacy of the NSAID. In these sessions, phasic pain was induced by intracutaneously applied brief electrical pulses (20 ms). Measured were the pain ratings, the cerebral potentials and the EEG delta power in responses to the stimuli as target variables for the analgesic test. Unspecific effects upon the vigilance system were evaluated by spontaneous EEG, auditory-evoked potentials and reaction times. The investigation was performed as a placebo-controlled, double-blind cross-over study. Blood samples were taken to monitor the plasma concentrations of the active agents. Whereas in the first block of stimuli (40-60 min after diclofenac medication) no analgesic effects of diclofenac could be observed, either given alone or after pretreatment with the B-vitamins, in the second stimulus block (100-120 min after medication) significant effects appeared in all target variables describing analgesia. Pain ratings were decreased by about 5%, late cerebral potentials by about 9% and stimulus-induced delta power of the EEG by about 14%. These effects were significant (p < 0.05, p < 0.01) against those under placebo, but came out to be independent of the B-vitamin pretreatment. No B-vitamin effects of the B-vitamins could be detected, either additive analgesic effects on diclofenac analgesia or on the concomitant variables describing unspecific sedative effects. Clearly the B-vitamin pretreatment for 1 week enlarged the plasma levels for vitamin B6 by 700%, for vitamin B1 by 70% and for vitamin B12 by 50%. All B-vitamin concentrations were independent of each other.
在38名健康志愿者中,采用非炎症性实验性疼痛模型,研究了长期口服维生素B1、B6、B12组合(硫胺二磷酸100毫克、盐酸吡哆醇200毫克、氰钴胺20微克)对单剂量非甾体抗炎药(NSAID)双氯芬酸(双氯芬酸钠,50毫克)的附加镇痛作用。B族维生素每天服用3次,共服用1周。然后进行3小时的实验,以测试NSAID的镇痛效果。在这些实验中,通过皮内施加短暂电脉冲(20毫秒)诱发阶段性疼痛。测量疼痛评分、脑电位和脑电图δ波功率,作为镇痛测试的目标变量,以响应刺激。通过自发脑电图、听觉诱发电位和反应时间评估对警觉系统的非特异性影响。该研究采用安慰剂对照、双盲交叉研究。采集血样以监测活性剂的血浆浓度。在第一组刺激(双氯芬酸用药后40 - 60分钟)中,无论是单独给予双氯芬酸还是在B族维生素预处理后,均未观察到双氯芬酸的镇痛作用;而在第二组刺激(用药后100 - 120分钟)中,所有描述镇痛的目标变量均出现显著作用。疼痛评分降低约5%,晚期脑电位降低约9%,脑电图刺激诱发的δ波功率降低约14%。这些作用与安慰剂组相比具有显著性(p < 0.05,p < 0.01),但结果表明与B族维生素预处理无关。未检测到B族维生素对双氯芬酸镇痛的附加镇痛作用,也未检测到对描述非特异性镇静作用的伴随变量的影响。显然,1周的B族维生素预处理使维生素B6的血浆水平提高了700%,维生素B1提高了70%,维生素B12提高了50%。所有B族维生素浓度相互独立。